Pharmaceutical companies are doing more to help people in developing countries obtain the drugs they need, according to the latest Access to Medicines Index... GlaxoSmithKline...continues to top the league table...Johnson & Johnson and...Sanofi are now close behind. The index...has become an authoritative guide... Drug companies are scored on a range of measures, from their willingness to discount prices in poor countries, to research on neglected diseases of poor people to lobbying, transparency and conduct in clinical trials...But there are concerns that Big Pharma is not demonstrating real influence over the private contractors...[that] carry out drug trials in the developing world. [other companies in index in order of ranking: Merck & Co., Gilead Sciences, Novo Nordisk, Novartis, Merck KGaA, Bayer, Roche, Pfizer, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly, Eisai, AstraZeneca, Boehringer-Ingelheim, Takeda Pharmaceutical, Daiichi Sanyko, Astellas Pharma]